Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
FI: 3,979
Type: Article
Artículo original
Year: 2016
Writers
Hernandez-Cruz, B; Marquez-Saavedra, E; Chalice-Calice, R; Navarro-Sarabia, F.
Magazine
Title: ARTHRITIS RESEARCH & THERAPY
Quartile
- Q1